Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Clinical and Immunological Effects of Rituximab With Cyclophosphamide Compared to Rituximab Alone in AAV Patients

NCT03942887 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT03942887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03942887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Clinical and Immunological Effects of Rituximab With Cyclophosphamide Compared to Rituximab Alone in AAV Patients
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
May 3, 2019
Completion date
April 1, 2025
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anca associated vasculitis